One year into his term as CEO of Evotec AG, Werner Lanthaler has completed his turnaround of the company and is looking to achieve sustained profitability by 2012 at the latest, driven primarily by the provision of discovery research services. (BioWorld International)
Yorkville Advisors LLC expanded its already large footprint in European biotechnology by entering another standby equity distribution agreement. (BioWorld International) BioWorld International Correspondent Yorkville Advisors LLC expanded its already large footprint in European biotechnology by entering another standby equity distribution agreement.
